In November, CCSN Health Policy Consultant Louise Binder gave a speech at the Conference Board of Canada dinner. Some topics covered included: the dichotomy in our health care systems, working within this basic construct of natural tensions in a world of limited resources, a professed desire for sustainability and growing health care demand. A copy of the speech can be found below. "Thank you so
The Honourable Allan Rock to be Honorary Chair for 2017 PCCNO Conference! FOR RELEASE Prostate Cancer Canada Network Ottawa (PCCNO) is pleased to announce that its 2017 conference “Prostate Cancer – Discover the Future” will be held at the Ottawa Convention and Event Centre, 200 Coventry Road, Ottawa on September 15 – 16, 2017. We are delighted that the Honourable Allan Rock has agreed to
Government-wide strategy will lead to a comprehensive ban to protect the health and safety of Canadians OTTAWA, Dec. 15, 2016 /CNW/ – Today, the Honourable Kirsty Duncan, Minister of Science, along with the Honourable Jane Philpott, Minister of Health, the Honourable Catherine McKenna, Minister of Environment and Climate Change, and the Honourable Judy M. Foote, Minister of Public Services and Procurement, announced that the Government of Canada will move forward
Are you a primary care provider? Do you see patients enrolled in clinical trials? We want to hear from you! The Office of Continuing Professional Development, Queen's University, in collaboration with AbbVie Pharmaceuticals, is inviting you to take part in a needs assessment survey to identify educational initiatives to support primary health care practitioners who have patients with a targeted disease enrolled in pharmaceutical clinical trials.
Below is a statement on behalf of the Canadian Medical Cannabis Council in regards to the Final Report of the Task Force on Cannabis Legalization and Regulation. Ottawa, ON – Philippe Lucas, Executive Director of CMCC today released the following statement regarding the release of the report by the Federal Task Force on Legalization: “We applaud the task force for a progressive report that strongly supports a
NEW YORK, Dec. 8, 2016 /PRNewswire/ — Earlier this year the Breast Cancer Research Foundation (BCRF) launched the Drug Research Collaborative, an unprecedented new funding model aimed at bridging the gap between academic investigators and new drugs in development. Today, BCRF announced nine new projects that are part of this ground-breaking collaboration between BCRF, Pfizer and the Translational Breast Cancer Research Consortium (TBCRC). The program—funded